Status:
RECRUITING
Physiologic MR Imaging of Salivary Gland Tumors
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
McCabe Fund
Conditions:
Salivary Gland Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment ...
Detailed Description
The goal of this proposed study is to investigate the potential utility of combined analysis of parameters (Ktrans, ti and ADC) in discriminating benign from malignant salivary glands tumors (SGTs). A...
Eligibility Criteria
Inclusion
- Possess a salivary gland lesion of 1cm3 size
- Have no prior history of treatment for salivary gland lesion
Exclusion
- Has any prior history of cancer other than SGT
- Has any MRI contra-indications
- Has a history of known renal disease.
- Has history of prior radiation to head and neck region
- Is pregnant
Key Trial Info
Start Date :
August 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04452162
Start Date
August 25 2020
End Date
June 1 2026
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104